190 related articles for article (PubMed ID: 28671602)
1. Mechanism Investigation of Rifampicin-Induced Liver Injury Using Comparative Toxicoproteomics in Mice.
Kim JH; Nam WS; Kim SJ; Kwon OK; Seung EJ; Jo JJ; Shresha R; Lee TH; Jeon TW; Ki SH; Lee HS; Lee S
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28671602
[TBL] [Abstract][Full Text] [Related]
2. Lipid peroxidation aggravates anti-tuberculosis drug-induced liver injury: Evidence of ferroptosis induction.
Pan Y; Tang P; Cao J; Song Q; Zhu L; Ma S; Zhang J
Biochem Biophys Res Commun; 2020 Dec; 533(4):1512-1518. PubMed ID: 33121683
[TBL] [Abstract][Full Text] [Related]
3. Attenuation of anti-tuberculosis therapy induced hepatotoxicity by Spirulina fusiformis, a candidate food supplement.
Martin SJ; Baskaran UL; Vedi M; Sabina EP
Toxicol Mech Methods; 2014 Dec; 24(8):584-92. PubMed ID: 25137345
[TBL] [Abstract][Full Text] [Related]
4. The inhibition of hepatic bile acids transporters Ntcp and Bsep is involved in the pathogenesis of isoniazid/rifampicin-induced hepatotoxicity.
Guo YX; Xu XF; Zhang QZ; Li C; Deng Y; Jiang P; He LY; Peng WX
Toxicol Mech Methods; 2015; 25(5):382-7. PubMed ID: 25886055
[TBL] [Abstract][Full Text] [Related]
5. The protective effects of ursodeoxycholic acid on isoniazid plus rifampicin induced liver injury in mice.
Chen X; Xu J; Zhang C; Yu T; Wang H; Zhao M; Duan ZH; Zhang Y; Xu JM; Xu DX
Eur J Pharmacol; 2011 May; 659(1):53-60. PubMed ID: 21419764
[TBL] [Abstract][Full Text] [Related]
6. Chinese herbal formula Fuzheng Huayu alleviates CCl
Dong S; Cai FF; Chen QL; Song YN; Sun Y; Wei B; Li XY; Hu YY; Liu P; Su SB
Acta Pharmacol Sin; 2018 Jun; 39(6):930-941. PubMed ID: 29094729
[TBL] [Abstract][Full Text] [Related]
7. KLF15-Cyp3a11 Axis Regulates Rifampicin-Induced Liver Injury.
Hou W; Huo KG; Guo X; Xu M; Yang Y; Shi Z; Xu W; Tu J; Gao T; Ma Z; Han S
Drug Metab Dispos; 2024 Jun; 52(7):606-613. PubMed ID: 38670799
[TBL] [Abstract][Full Text] [Related]
8. First-line anti-tuberculosis drugs induce hepatotoxicity: A novel mechanism based on a urinary metabolomics platform.
Cao J; Mi Y; Shi C; Bian Y; Huang C; Ye Z; Liu L; Miao L
Biochem Biophys Res Commun; 2018 Mar; 497(2):485-491. PubMed ID: 29454961
[TBL] [Abstract][Full Text] [Related]
9. Toxicoproteomic Profiling of
Brewer CT; Kodali K; Wu J; Shaw TI; Peng J; Chen T
Cells; 2020 Jul; 9(7):. PubMed ID: 32660103
[TBL] [Abstract][Full Text] [Related]
10. Transcriptomic analysis reveals the mechanism of sulfasalazine-induced liver injury in mice.
Li YC; Shen JD; Lu SF; Zhu LL; Wang BY; Bai M; Xu EP
Toxicol Lett; 2020 Mar; 321():12-20. PubMed ID: 31830553
[TBL] [Abstract][Full Text] [Related]
11. Changes in Bile Acid Concentrations after Administration of Ketoconazole or Rifampicin to Chimeric Mice with Humanized Liver.
Sanoh S; Tamura Y; Fujino C; Sugahara G; Yoshizane Y; Yanagi A; Kisoh K; Ishida Y; Tateno C; Ohta S; Kotake Y
Biol Pharm Bull; 2019; 42(8):1366-1375. PubMed ID: 31366871
[TBL] [Abstract][Full Text] [Related]
12. Sagittaria sagittifolia polysaccharide protects against isoniazid- and rifampicin-induced hepatic injury via activation of nuclear factor E2-related factor 2 signaling in mice.
Wang J; Luo W; Li B; Lv J; Ke X; Ge D; Dong R; Wang C; Han Y; Zhang C; Yu H; Liao Y
J Ethnopharmacol; 2018 Dec; 227():237-245. PubMed ID: 30194055
[TBL] [Abstract][Full Text] [Related]
13. Human PXR modulates hepatotoxicity associated with rifampicin and isoniazid co-therapy.
Li F; Lu J; Cheng J; Wang L; Matsubara T; Csanaky IL; Klaassen CD; Gonzalez FJ; Ma X
Nat Med; 2013 Apr; 19(4):418-20. PubMed ID: 23475203
[TBL] [Abstract][Full Text] [Related]
14. SLCO1B1 *15 haplotype is associated with rifampin-induced liver injury.
Li LM; Chen L; Deng GH; Tan WT; Dan YJ; Wang RQ; Chen WS
Mol Med Rep; 2012 Jul; 6(1):75-82. PubMed ID: 22562052
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenetic & pharmacokinetic biomarker for efavirenz based ARV and rifampicin based anti-TB drug induced liver injury in TB-HIV infected patients.
Yimer G; Ueda N; Habtewold A; Amogne W; Suda A; Riedel KD; Burhenne J; Aderaye G; Lindquist L; Makonnen E; Aklillu E
PLoS One; 2011; 6(12):e27810. PubMed ID: 22162992
[TBL] [Abstract][Full Text] [Related]
16. Protective Effect of Bicyclol on Anti-Tuberculosis Drug Induced Liver Injury in Rats.
Liu X; Zhao M; Mi J; Chen H; Sheng L; Li Y
Molecules; 2017 Apr; 22(4):. PubMed ID: 28387740
[TBL] [Abstract][Full Text] [Related]
17. Potentiating effect of rifampicin on methimazole induced hepatotoxicity in mice.
Hakim Z; Waheed A; Bakhtiar S; Hasan N; Hakim B
Pak J Pharm Sci; 2018 Nov; 31(6):2373-2377. PubMed ID: 30473507
[TBL] [Abstract][Full Text] [Related]
18. Acetaminophen Induced Hepatotoxicity in Wistar Rats--A Proteomic Approach.
Ilavenil S; Al-Dhabi NA; Srigopalram S; Ock Kim Y; Agastian P; Baru R; Choi KC; Valan Arasu M
Molecules; 2016 Jan; 21(2):161. PubMed ID: 26828476
[TBL] [Abstract][Full Text] [Related]
19. Hepatotoxicity in patients co-infected with tuberculosis and HIV-1 while receiving non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy and rifampicin-containing anti-tuberculosis regimen.
Mankhatitham W; Lueangniyomkul A; Manosuthi W
Southeast Asian J Trop Med Public Health; 2011 May; 42(3):651-8. PubMed ID: 21706943
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and safety/tolerability of higher oral and intravenous doses of rifampicin in adult tuberculous meningitis patients.
Yunivita V; Dian S; Ganiem AR; Hayati E; Hanggono Achmad T; Purnama Dewi A; Teulen M; Meijerhof-Jager P; van Crevel R; Aarnoutse R; Ruslami R
Int J Antimicrob Agents; 2016 Oct; 48(4):415-21. PubMed ID: 27526979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
